2025年全球製氧机市场报告

预计未来几年人工肺市场将快速成长。到 2029 年，这一数字将成长至 40.6 亿美元，复合年增长率为 11.9%。预测期内的成长是由于呼吸系统疾病盛行率上升、医疗设施改善、微创手术接受度提高、患者生活品质改善、慢性阻塞性肺病盛行率上升。预测期内的关键趋势包括无线技术的融合、人工智慧 (AI) 的融合、基因组学和医疗技术的进步以及更小、更便携的人工肺的开发。

由于呼吸系统疾病的日益流行，人工肺市场预计将会成长。受空气污染加剧、气候变迁和生活方式改变等因素的影响，这种增长给公众健康带来了巨大负担。人工肺透过提供氧气、去除血液中的二氧化碳以及支持或替代受损的肺功能，在呼吸系统疾病的治疗中发挥着至关重要的作用。例如，根据澳洲健康与福利研究所2024年6月的报告，估计澳洲约有850万人，即34%的人口患有慢性呼吸道疾病。其中，280 万人（占总人口的 11%）患有气喘，638,000 人（占总人口的 2.5%）患有慢性阻塞性肺病(COPD)。因此，呼吸系统疾病盛行率的不断上升是人工肺部市场扩张的关键驱动力。

为了获得竞争优势，氧合器市场的主要企业正专注于开拓创新解决方案，例如远端监控和控制系统。这些系统允许医疗专业人员远端监测患者的生命征象并调整呼吸设置，而无需站在床边。这种方法有助于降低感染风险并提高治疗期间患者的安全性。例如，2022年8月，美国电子製造商Teltonika Telemedic在其人工肺人工呼吸器TELTOMED的研发中取得重大突破。该公司已获得人工呼吸器安全远端传输和控制的独家专利，提高了现代医疗设备至关重要的患者资料通讯的安全性和可靠性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球人工肺PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球製氧机市场：成长率分析
• 全球製氧机市场表现：规模与成长，2019-2024
• 全球製氧机市场预测：规模与成长，2024-2029 年，2034 年
• 氧合器的全球总目标市场（TAM）

第六章市场区隔

• 全球製氧机市场：按产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 单滚轮泵心肺机
• 双滚轮泵心肺机
• 气泡氧合器
• 膜式氧合器
• 全球人工肺市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 心血管手术
• 肺移植手术
• 急性呼吸衰竭的治疗
• 其他用途
• 全球製氧机市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 急诊中心
• 其他最终用户
• 全球氧合器市场单滚轮泵型心肺氧合器细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 可携式单滚轮泵心肺机
• 固定式单滚轮泵式体外循环机
• 全球氧合器市场双滚泵心肺氧合器细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 可携式双滚泵体外循环机
• 固定式双滚轮帮浦式体外循环机
• 全球製氧机市场气泡製氧机细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 一次使用气泡氧合器
• 可重复使用的气泡氧合器
• 全球氧合器市场膜氧合器细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 氧合膜氧合器
• 二氧化碳脱除膜氧合器

第七章 区域和国家分析

• 全球製氧机市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球製氧机市场：依国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 人工肺市场：竞争格局
• 氧合器市场：公司简介
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
  • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• TransMedics Group Inc.
• Braile Biomedica Ltd.
• Xenios AG
• MC3 Cardiopulmonary Inc.
• Lung Biotechnology PBC
• Breethe Inc.
• Levitronix LLC
• Medos Medizintechnik AG
• ALung Technologies Inc.
• McGowan Institute for Regenerative Medicine
• Hemovent GmbH
• Novalung GmbH
• Haemair Ltd.
• MedArray Inc.
• Vivonics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年氧合器市场：提供新机会的国家
• 2029 年氧合器市场：细分市场带来新机会
• 2029年制氧机市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing awareness among healthcare professionals, increasing market penetration, increasing applications in-home care setting, the rise in medical tourism, and improvements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, improvements in healthcare facilities, rising acceptance of minimally invasive procedures, enhanced patient quality of life, and rising prevalence of chronic obstructive pulmonary diseases. Major trends in the forecast period include the integration of wireless technology, artificial intelligence (AI) integration, advances in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Major companies in the artificial lung market are focusing on developing innovative solutions, such as remote monitoring and control systems, to gain a competitive edge. These systems enable healthcare professionals to monitor patients' vital signs and adjust ventilation settings remotely, without needing to be physically present at the bedside. This approach helps reduce the risk of infection and improves patient safety during treatment. For example, in August 2022, Teltonika Telemedic, a U.S.-based electronics manufacturer, made significant strides in developing its artificial lung ventilator, TELTOMED. The company secured an exclusive patent for the secure remote transmission and control of its ventilator, enhancing the security and reliability of patient data communication-an essential feature for modern medical devices.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
• 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
• 3) By End-Users: Hospital; Emergency Center; Other End-users
• Subsegments:
• 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
• 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
• 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
• 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
• Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Lung Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Lung Market Growth Rate Analysis
• 5.4. Global Artificial Lung Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Lung Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Lung Total Addressable Market (TAM)

6. Artificial Lung Market Segmentation

• 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Roller Pump Heart Lung Machines
• Double Roller Pump Heart Lungs Machines
• Bubble Artificial Lung
• Membrane Artificial Lung
• 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Surgery
• Lung Transplant Operation
• Acute Respiratory Failure Treatment
• Other Applications
• 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Emergency Center
• Other End-user
• 6.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Single Roller Pump Heart Lung Machines
• Stationary Single Roller Pump Heart Lung Machines
• 6.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Double Roller Pump Heart Lung Machines
• Stationary Double Roller Pump Heart Lung Machines
• 6.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Bubble Artificial Lung
• Reusable Bubble Artificial Lung
• 6.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxygenator Membrane Artificial Lung
• Carbon Dioxide Removal Membrane Artificial Lung

7. Artificial Lung Market Regional And Country Analysis

• 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Lung Market

• 8.1. Asia-Pacific Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Lung Market

• 9.1. China Artificial Lung Market Overview
• 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Lung Market

• 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Lung Market

• 11.1. Japan Artificial Lung Market Overview
• 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Lung Market

• 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Lung Market

• 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Lung Market

• 14.1. South Korea Artificial Lung Market Overview
• 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Lung Market

• 15.1. Western Europe Artificial Lung Market Overview
• 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Lung Market

• 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Lung Market

• 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Lung Market

• 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Lung Market

• 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Lung Market

• 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Lung Market

• 21.1. Eastern Europe Artificial Lung Market Overview
• 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Lung Market

• 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Lung Market

• 23.1. North America Artificial Lung Market Overview
• 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Lung Market

• 24.1. USA Artificial Lung Market Overview
• 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Lung Market

• 25.1. Canada Artificial Lung Market Overview
• 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Lung Market

• 26.1. South America Artificial Lung Market Overview
• 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Lung Market

• 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Lung Market

• 28.1. Middle East Artificial Lung Market Overview
• 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Lung Market

• 29.1. Africa Artificial Lung Market Overview
• 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

• 30.1. Artificial Lung Market Competitive Landscape
• 30.2. Artificial Lung Market Company Profiles
  • 30.2.1. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Lung Market Other Major And Innovative Companies

• 31.1. TransMedics Group Inc.
• 31.2. Braile Biomedica Ltd.
• 31.3. Xenios AG
• 31.4. MC3 Cardiopulmonary Inc.
• 31.5. Lung Biotechnology PBC
• 31.6. Breethe Inc.
• 31.7. Levitronix LLC
• 31.8. Medos Medizintechnik AG
• 31.9. ALung Technologies Inc.
• 31.10. McGowan Institute for Regenerative Medicine
• 31.11. Hemovent GmbH
• 31.12. Novalung GmbH
• 31.13. Haemair Ltd.
• 31.14. MedArray Inc.
• 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Lung Market

34. Recent Developments In The Artificial Lung Market

35. Artificial Lung Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Lung Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Lung Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Lung Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer